Medicare Enrolled

Dr. Chirag Dave, M.D.

Urology Physician · Marietta, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Research-focused
1371 CHURCH STREET EXT NE STE 200, Marietta, GA 30060
6783448900
In practice since 2013 (13 years)
NPI: 1205273091 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dave from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dave? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dave

Dr. Chirag Dave is an urology physician in Marietta, GA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Dave performed 1,533 Medicare services across 1,162 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dave received a total of $60,768 from 45 pharmaceutical and/or device companies across 165 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dave is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ 1,533 Medicare services $60,768 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,533
Medicare services
Bottom 45% in GA for urology physician
1,162
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~118 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
451 $94 $464
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
265 $8 $39
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
243 $2 $8
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
122 $120 $606
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
98 $80 $400
Urinalysis for bacteria
A urine test to check for the presence of bacteria. This procedure analyzes a urine sample to detect bacterial growth.
95 $29 $111
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
36 $71 $335
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
34 $7 $51
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
28 $19 $283
Sacral nerve stimulator electrode insertion
A procedure to place an electrode array in the sacral area to deliver electrical stimulation to the nerves.
22 $304 $1,177
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
20 $182 $884
Bladder dilation using endoscope
A procedure where a doctor uses a thin, flexible tube with a camera to widen the bladder.
20 $289 $1,374
Injection, garamycin, gentamicin, up to 80 mg 19 $2 $10
Non-needle muscle activity measurement of bladder and bowel openings
This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles.
17 $27 $234
Other procedure on male genital system
A surgical or medical intervention performed on the male genital organs that does not fall under other specific categories.
16 $133 $1,419
Injection to cause erection
A procedure involving an injection administered to induce an erection.
12 $56 $328
Ultrasound of penis artery and vein blood flow
An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins of the penis.
12 $92 $423
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
12 $33 $206
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
11 $10 $45
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$60,768
Total received (2018-2024)
Avg $8,681/year across 7 years
Top 4% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
165
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Scientific / Research
Research funding and grants
$50,026 (82.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,725 (17.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$18 (0.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,183
2023
$797
2022
$1,081
2021
$787
2020
$676
2019
$4,549
2018
$50,695

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
COLOPLAST CORP
$607
PROCEPT BioRobotics Corporation
$502
Teleflex LLC
$290
Axonics, Inc.
$267
ConvaTec Inc.
$204
Novo Nordisk Inc
$159
Olympus America Inc.
$31
Bayer Healthcare Pharmaceuticals Inc.
$28
Endo USA, Inc.
$26
Sumitomo Pharma America, Inc.
$24
AstraZeneca Pharmaceuticals LP
$24
Tolmar, Inc.
$20
Top 3 companies account for 64.1% of 2024 payments
All-time payments by company (2018-2024) ›
BOSTON SCIENTIFIC CORPORATION
$50,026
Coloplast Corp
$4,717
Teleflex LLC
$976
PROCEPT BioRobotics Corporation
$899
COLOPLAST CORP
$682
Endo Pharmaceuticals Inc.
$453
Axonics, Inc.
$310
ConvaTec Inc.
$252
Boston Scientific Corporation
$219
Dendreon Pharmaceuticals LLC
$194
NeoTract Inc.
$162
Novo Nordisk Inc
$159
Laborie Medical Technologies Corp.
$147
Myriad Genetic Laboratories, Inc.
$143
Metuchen Pharmaceuticals
$121
Osiris Therapeutics Inc.
$121
AstraZeneca Pharmaceuticals LP
$109
Sumitomo Pharma America, Inc.
$107
Abbott Laboratories
$107
UROVANT SCIENCES INC
$96
Antares Pharma, Inc.
$85
Axonics Modulation Technologies, Inc.
$84
Medtronic USA, Inc.
$65
Astellas Pharma US Inc
$49
Bayer HealthCare Pharmaceuticals Inc.
$40
Medtronic, Inc.
$32
Olympus America Inc.
$31
Merck Sharp & Dohme LLC
$30
Mission Pharmacal Company
$29
Ambu Inc.
$29
Baxter Healthcare
$29
Bayer Healthcare Pharmaceuticals Inc.
$28
Endo USA, Inc.
$26
TOLMAR Pharmaceuticals, Inc.
$24
Janssen Biotech, Inc.
$23
ABBVIE INC.
$22
Tolmar, Inc.
$20
Allergan, Inc.
$20
DENTSPLY IH Inc.
$19
Acerus Pharmaceuticals Corporation
$18
Travere Therapeutics, Inc.
$18
ROCHESTER MEDICAL CORPORATION
$14
UROGEN PHARMA, INC.
$12
PFIZER INC.
$12
Zyla Life Sciences, Inc.
$11
Top 3 companies account for 91.7% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AMS · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · ARTISS · AVEED · AquaBeam Robotic System · Axonics · Axonics r-SNM System · BOTOX · Bulkamid · EDEX · ELIGARD · ERLEADA · GEMTESA · GENERAL MALE SUI · GENTLECATH · GENTLECATH GLIDE · GRAFIX/GRAFIXPL/STRAVIX · INTERSTIM · JELMYTO · KEYTRUDA · LYNPARZA · LoFric · Myrbetriq · NOCDURNA · Natesto · Nubeqa · ORGOVYX · Otrexup · PENILE & TESTICULAR RECONSTRUCTN · PROVENGE · Proclaim IPG · Prolaris · SPRIX · Stendra · TITAN · Thiola · Titan · UROLIFT · Uribel · UroLift · UroLift System · Virtue · XIAFLEX · XTANDI · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (82%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work. Total industry engagement is in the top 4% for urology physician in GA.

Looking for an urology physician in Marietta?
Compare urology physicians in the Marietta area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
142
Per 100K population
18.5
County median income
$98,712
Nearest hospital
WELLSTAR KENNESTONE REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dave is a clinical cardiology specialist, with moderate Medicare volume, with research-focused industry engagement in the top 4% of GA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Dave experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Dave performed 451 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dave receive payments from pharmaceutical companies?
Yes. Dr. Dave received a total of $60,768 from 45 companies across 165 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dave's costs compare to other urology physicians in Marietta?
Dr. Dave's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dave) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →